Aspirin
Brand names: Disprin, Nu-Seals, Micropirin
Low-dose aspirin is an antiplatelet for secondary prevention of cardiovascular events and in acute coronary syndromes; higher doses are analgesic and antipyretic.
Adult dose
Dose adjustments
Use with caution in patients with impaired renal function; avoid if severe.
Dose auto-extracted from UK Summary of Product Characteristics (SPC) via the eMC; US FDA prescribing information (openFDA / DailyMed) — cross-check; US labelling may differ from UK — not yet clinician-verified. Always confirm against the product SmPC and your local formulary before prescribing.
US labelling (FDA)
Reference — US labelling, may differ from UKDirections drink a full glass of water with each dose adults and children 12 years and over: take 4 to 8 tablets every 4 hours not to exceed 48 tablets in 24 hours unless directed by a doctor children under 12 years: consult a doctor
Source: US FDA prescribing information (openFDA / DailyMed), label dated 2024-04-16. Accessed 2026-06-12. US dosing and indications can differ from UK practice — use UK sources for prescribing decisions.
Contraindications
- Hypersensitivity to the active substance or to any of the excipients
- Hypoprothrombinaemia, haemophilia, haemorrhagic disease or a history of bleeding disorders
- Cerebral haemorrhage
- Active peptic ulceration or a history of peptic ulceration
- Third trimester of pregnancy
- Women who are breastfeeding
Side effects
- Gastrointestinal irritation, nausea, vomiting, dyspepsia, gastritis, gastrointestinal erosions/ulcer/bleeding (most common adverse events)
- Hypersensitivity reactions including skin rashes, urticaria, angioedema, asthma, bronchospasm and anaphylaxis
- Anaemia, bleeding disorders, thrombocytopenia
- Tinnitus
- Cerebral haemorrhage; haematoma, haemorrhage; epistaxis; prolonged bleeding time
Interactions
- Metamizole may reduce the antiplatelet effect of acetylsalicylic acid (caution with low-dose aspirin for cardioprotection)
- Salicylates may enhance the effect of oral hypoglycaemic agents, phenytoin and sodium valproate
- Inhibit the uricosuric effect of probenecid and may increase the toxicity of sulphonamides
- ACE inhibitors: aspirin at higher doses decreases glomerular filtration and antihypertensive effect
- Diuretics: can increase the risk of nephrotoxicity of NSAIDs
Clinical monograph
How it works
It irreversibly inhibits platelet cyclo-oxygenase-1, reducing thromboxane-A2-mediated aggregation for the lifespan of the platelet.
Prescribing in practice
- Gastrointestinal irritation and bleeding occur — consider gastroprotection in at-risk patients.
- It can trigger bronchospasm in aspirin-sensitive asthma.
- Avoid in children under 16 (Reye's syndrome) except for specific indications; bleeding risk rises with other antithrombotics.
Monitoring
Watch for gastrointestinal symptoms and bleeding.
Counselling the patient
- Take it with or after food.
- Report indigestion, black stools or unusual bleeding.
- Do not give aspirin to children unless specifically told to.
Evidence & guidelines
Established for secondary cardiovascular prevention; routine primary prevention is no longer generally recommended.
Reference: NICE NG185 (ACS, 2020); NICE NG128 (Stroke, 2022); NICE NG17 (Headaches); ESC Guidelines on ACS (2023); ASCEND trial (NEJM 2018); Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. The structured dose values shown have been reviewed by a clinician. Monograph status: clinician-reviewed (2026-07-04).
Related
Curated clinical cross-links plus same-class fallbacks.
- HEART Score for Major Adverse Cardiac EventsRecommendedChest Pain
- HAS-BLED ScoreRecommendedBleeding Risk
- CHADS₂ Score for AF Stroke RiskRecommendedStroke Risk
- Acute Heart Failure · ESC 2021 Heart Failure Guidelines; NICE NG106
- NSTEMI / Unstable Angina · ESC 2020 NSTEMI Guidelines; NICE NG185
- New-Onset Atrial Fibrillation · ESC 2020 AF Guidelines; NICE NG196
- Hypertensive Emergency · ESC/ESH 2018 Hypertension Guidelines; NICE NG136
- Bradycardia Management · Resuscitation Council UK ABCDE; ESC 2021 Pacing Guidelines